Bart Frazzitta was told he had a 5% chance of surviving esophageal cancer. Twenty-five years later, he's still here and ...
Palliative care consultations helped patients with esophageal cancer at end-of-life experience better quality of life and less financial strain by reducing the need for intensive interventions, ...
A dad-of-four who underwent a major operation for esophageal cancer is keen to help others after coming through the other ...
the most common esophageal cancer type in the U.S., often occurs in the lower esophagus and is rising in incidence globally. To combat this unmet need in patients, Merck currently has more than 1,600 ...
Netherlands: A recent retrospective cohort study has shed light on the connection between esophageal Candida infection and an ...
HealthDay News — For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) leads to improved survival compared ...
It’s been 25 years since the surgery, and the 82-year-old Frazzitta not only is still living — he’s become a leading resource for both esophageal cancer patients and doctors who treat them.